Pediatrix Medical Group, Inc. (MD)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $856k
- May 13 · Unusual
- Form 4 sales
- 226
- On record
- Form 144 notices
- 7
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planAug 27 2024
Sold 7,000 shares at $11.16 ($78k)
Linynsky Laura A, Director
No 10b5-1 planSold 18.5% of holdings ($422k position)30,805 shares leftFirst sale on recordFiling
- 2 Form 4 saleNo planAug 30 +3 days
Sold 11,100 shares at $10.79 ($120k)
Swift James D, Chief Executive Officer
No 10b5-1 planSold 6.1% of holdings ($2M position)170,001 shares left0.8x usual sizeFiling
- 3 Form 4 saleNo planNov 8 +70 days
Sold 8,108 shares at $16.00 ($130k)
Moore Mary Ann E, EVP, GC, Chief Admin Off & Sec
No 10b5-1 planSold 5.6% of holdings ($2.3M position)135,810 shares leftFiling
- 4 Form 4 saleNo planNov 13 +5 days
Sold 27,600 shares at $15.35 ($424k)
Ordan Mark S, Director
No 10b5-1 planSold 16.6% of holdings ($2.6M position)138,683 shares leftFiling
- 5 Form 4 saleNo planNov 6 +358 days
Sold 10,000 shares at $21.65 ($217k)
Linynsky Laura A, Director
No 10b5-1 planSold 23.7% of holdings ($914k position)32,232 shares leftFiling
- 6 Form 4 saleNo planNov 17 +11 days
Sold 10,478 shares at $23.00 ($241k)
Rucker Michael A., Director
No 10b5-1 planSold 15.1% of holdings ($1.6M position)59,101 shares leftFirst sale on recordFiling
- 7 Form 4 saleNo planDec 15 +28 days
Sold 23,000 shares at $22.41 ($515k)
Ordan Mark S, Chief Executive Officer
No 10b5-1 planSold 7.1% of holdings ($7.3M position)302,805 shares leftFiling
- 8 Form 4 saleUnusualMay 13 +149 days
Sold 36,028 shares at $23.75 ($856k)
Weis Shirley A, Director
No 10b5-1 planSold 100% of holdings ($856k position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (233)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | Weis Shirley A | Director | Form 4 sale | 36,028 | $856k | 100.0% | Unusual | SEC |
| Dec 15, 2025 | Ordan Mark S | Chief Executive Officer | Form 4 sale | 23,000 | $515k | 7.1% | No plan | SEC |
| Nov 17, 2025 | Rucker Michael A. | Director | Form 4 sale | 10,478 | $241k | 15.1% | No plan | SEC |
| Nov 6, 2025 | Linynsky Laura A | Director | Form 4 sale | 10,000 | $217k | 23.7% | No plan | SEC |
| Nov 13, 2024 | Ordan Mark S | Director | Form 4 sale | 27,600 | $424k | 16.6% | No plan | SEC |
| Nov 8, 2024 | Moore Mary Ann E | EVP, GC, Chief Admin Off & Sec | Form 4 sale | 8,108 | $130k | 5.6% | No plan | SEC |
| Aug 30, 2024 | Swift James D | Chief Executive Officer | Form 4 sale | 11,100 | $120k | 6.1% | No plan | SEC |
| Aug 27, 2024 | Linynsky Laura A | Director | Form 4 sale | 7,000 | $78k | 18.5% | No plan | SEC |
| Aug 12, 2024 | Richards C Marc | EVP, Chief Financial Officer | Form 4 sale | 50,000 | $504k | 22.2% | No plan | SEC |
| Dec 14, 2023 | Moore Mary Ann E | EVP, General Counsel & Sec | Form 4 sale | 2,120 | $20k | 11.9% | No plan | SEC |
| Dec 14, 2023 | Swift James D | Chief Executive Officer | Form 4 sale | 5,764 | $55k | 6.0% | No plan | SEC |
| Dec 14, 2023 | Swift James D | Officer | Form 144 notice | 5,764 | $55k | Notice | SEC | |
| Jun 14, 2023 | Swift James D | Chief Executive Officer | Form 4 sale | 13,193 | $187k | 12.0% | No plan | SEC |
| Jun 14, 2023 | Swift James D | Officer | Form 144 notice | 13,193 | $187k | Notice | SEC | |
| May 25, 2023 | Ordan Mark S | Director | Form 4 sale | 33,000 | $438k | 18.2% | No plan | SEC |
| May 24, 2023 | Ordan Mark S | Director | Form 144 notice | 33,000 | $446k | Notice | SEC | |
| May 19, 2023 | Weis Shirley A | Director | Form 4 sale | 19,000 | $258k | 51.8% | Unusual | SEC |
| May 19, 2023 | Weis Shirley A | Director | Form 144 notice | 1,007 | $14k | Notice | SEC | |
| May 18, 2023 | Weis Shirley A | Director | Form 144 notice | 17,993 | $244k | Notice | SEC | |
| May 12, 2023 | Medel Roger Md | Affiliate | Form 144 notice | 227,734 | $3.1M | Notice | SEC | |
| May 10, 2023 | Medel Roger Md | Affiliate | Form 144 notice | 50,000 | $675k | Notice | SEC | |
| Nov 21, 2022 | Ordan Mark S | Chief Executive Officer | Form 4 sale | 22,166 | $342k | 6.0% | Plan not stated | SEC |
| Nov 7, 2022 | Swift James D | EVP, Chief Operating Officer | Form 4 sale | 24,000 | $367k | 21.4% | Plan not stated | SEC |
| Jan 11, 2022 | Medel Roger Md | Director | Form 4 sale | 100,000 | $2.6M | 11.9% | Plan not stated | SEC |
| Jan 5, 2022 | Medel Roger Md | Director | Form 4 sale | 12,639 | $347k | 1.5% | Plan not stated | SEC |
| Jan 4, 2022 | Medel Roger Md | Director | Form 4 sale | 93,925 | $2.6M | 9.9% | Plan not stated | SEC |
| Dec 30, 2021 | Medel Roger Md | Director | Form 4 sale | 45,397 | $1.2M | 4.6% | Plan not stated | SEC |
| Dec 29, 2021 | Medel Roger Md | Director | Form 4 sale | 136,382 | $3.7M | 12.1% | Plan not stated | SEC |
| Nov 10, 2021 | Hinson Roger Mack | Pres., PDX & OBX Medical Group | Form 4 sale | 8,800 | $250k | 7.6% | Plan not stated | SEC |
| Nov 10, 2021 | Pepia John C | Principal Accounting Officer | Form 4 sale | 5,000 | $142k | 4.9% | Plan not stated | SEC |
| Oct 29, 2021 | Pepia John C | Principal Accounting Officer | Form 4 sale | 9,238 | $248k | 8.3% | Plan not stated | SEC |
| Oct 28, 2021 | Medel Roger Md | Director | Form 4 sale | 10,387 | $301k | 0.9% | Plan not stated | SEC |
| Oct 4, 2021 | Medel Roger Md | Director | Form 4 sale | 1,270 | $37k | 0.1% | Plan not stated | SEC |
| Sep 2, 2021 | Pepia John C | Principal Accounting Officer | Form 4 sale | 10,000 | $318k | 8.3% | Plan not stated | SEC |
| Aug 30, 2021 | Ordan Mark S | Chief Executive Officer | Form 4 sale | 95,000 | $3.3M | 31.3% | Unusual | SEC |
| Aug 10, 2021 | Hinson Roger Mack | Pres., PDX & OBX Medical Group | Form 4 sale | 8,799 | $285k | 7.0% | Plan not stated | SEC |
| Jul 1, 2021 | Medel Roger Md | Director | Form 4 sale | 100,000 | $3M | 7.6% | Plan not stated | SEC |
| Apr 1, 2021 | Medel Roger Md | Director | Form 4 sale | 100,000 | $2.5M | 7.1% | Plan not stated | SEC |
| Jan 4, 2021 | Medel Roger Md | Director | Form 4 sale | 100,000 | $2.4M | 6.3% | Plan not stated | SEC |
| Dec 10, 2020 | Medel Roger Md | Director | Form 4 sale | 100,000 | $2.3M | 5.9% | Plan not stated | SEC |
| Sep 15, 2020 | Nikolopoulos Nicholas J | EVP Chf Strategy & Growth Offi | Form 4 sale | 10,000 | $190k | 12.2% | Plan not stated | SEC |
| Sep 15, 2020 | Andreano Dominic J | EVP, General Counsel and Secy | Form 4 sale | 22,000 | $416k | 29.1% | Unusual | SEC |
| Nov 1, 2019 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 5,000 | $114k | 31.6% | Unusual | SEC |
| Sep 3, 2019 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 5,000 | $104k | 24.0% | Plan not stated | SEC |
| Mar 13, 2019 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 3,300 | $100k | 13.7% | Plan not stated | SEC |
| Mar 7, 2019 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 4,608 | $139k | 6.7% | Plan not stated | SEC |
| Mar 1, 2019 | Clark David A. | Chief Operating Officer | Form 4 sale | 6,452 | $212k | 4.5% | Plan not stated | SEC |
| Mar 1, 2019 | Calabro Joseph M | President | Form 4 sale | 12,130 | $399k | 2.7% | Plan not stated | SEC |
| Feb 20, 2019 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 1,289 | $47k | 1.8% | Plan not stated | SEC |
| Jan 22, 2019 | Pepia John C | Principal Accounting Officer | Form 4 sale | 2,500 | $92k | 8.0% | Plan not stated | SEC |
| Aug 14, 2018 | Pepia John C | Principal Accounting Officer | Form 4 sale | 3,500 | $169k | 11.3% | Plan not stated | SEC |
| Jun 12, 2018 | Pepia John C | Principal Accounting Officer | Form 4 sale | 6,516 | $303k | 17.3% | Plan not stated | SEC |
| Jun 12, 2018 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 13,942 | $648k | 12.2% | Plan not stated | SEC |
| Jun 11, 2018 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 18,000 | $845k | 42.0% | Unusual | SEC |
| Jun 1, 2018 | Calabro Joseph M | President and COO | Form 4 sale | 22,186 | $1M | 6.3% | Plan not stated | SEC |
| Jun 1, 2018 | Clark David A. | Pres. Mednax Natl Med Group | Form 4 sale | 11,607 | $524k | 26.1% | Unusual | SEC |
| May 22, 2018 | Pepia John C | Principal Accounting Officer | Form 4 sale | 3,000 | $139k | 7.6% | Plan not stated | SEC |
| Mar 13, 2018 | Pepia John C | Principal Accounting Officer | Form 4 sale | 3,000 | $175k | 7.6% | Plan not stated | SEC |
| Dec 12, 2017 | Pepia John C | Principal Accounting Officer | Form 4 sale | 3,000 | $155k | 8.4% | Plan not stated | SEC |
| Nov 3, 2017 | Alvarez Cesar L | Director | Form 4 sale | 10,668 | $454k | 24.1% | Plan not stated | SEC |
| Sep 12, 2017 | Pepia John C | Principal Accounting Officer | Form 4 sale | 3,000 | $129k | 8.4% | Plan not stated | SEC |
| Jun 14, 2017 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 1,969 | $113k | 9.8% | Plan not stated | SEC |
| Jun 1, 2017 | Clark David A. | Pres. Mednax Natl Med Group | Form 4 sale | 10,202 | $561k | 28.9% | Unusual | SEC |
| Jun 1, 2017 | Calabro Joseph M | President and COO | Form 4 sale | 23,327 | $1.3M | 8.2% | Plan not stated | SEC |
| May 5, 2017 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 7,778 | $434k | 13.2% | Plan not stated | SEC |
| Mar 15, 2017 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 6,517 | $462k | 26.3% | Unusual | SEC |
| Feb 23, 2017 | Sosa Enrique | Director | Form 4 sale | 10,668 | $743k | 48.7% | Unusual | SEC |
| Feb 17, 2017 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 15,164 | $1.1M | 20.4% | Plan not stated | SEC |
| Feb 16, 2017 | Pepia John C | Principal Accounting Officer | Form 4 sale | 2,500 | $174k | 8.1% | Plan not stated | SEC |
| Feb 16, 2017 | Gabos Paul G | Director | Form 4 sale | 21,336 | $1.5M | 65.5% | Unusual | SEC |
| Feb 16, 2017 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 6,000 | $418k | 19.5% | Plan not stated | SEC |
| Feb 10, 2017 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 25,294 | $1.7M | 58.8% | Unusual | SEC |
| Feb 9, 2017 | Waldemar, Md Carlo A | Director | Form 4 sale | 5,334 | $362k | 32.2% | Unusual | SEC |
| Jan 17, 2017 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 10,000 | $710k | 11.9% | Plan not stated | SEC |
| Sep 14, 2016 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 1,500 | $98k | 11.8% | Plan not stated | SEC |
| Jun 13, 2016 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 3,922 | $270k | 13.7% | Plan not stated | SEC |
| Jun 8, 2016 | Waldemar, Md Carlo A | Director | Form 4 sale | 5,334 | $376k | 32.2% | Unusual | SEC |
| Jun 7, 2016 | Wagner Karl B | President, Eastern Division | Form 4 sale | 27,482 | $1.9M | 20.6% | Plan not stated | SEC |
| Jun 1, 2016 | Clark David A. | President, Western Division | Form 4 sale | 11,470 | $777k | 36.4% | Unusual | SEC |
| Jun 1, 2016 | Stanley Michael D | President, Clinical Services | Form 4 sale | 14,778 | $1M | 29.5% | Unusual | SEC |
| Jun 1, 2016 | Calabro Joseph M | President and COO | Form 4 sale | 28,347 | $1.9M | 11.0% | Plan not stated | SEC |
| May 16, 2016 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 3,000 | $206k | 12.3% | Plan not stated | SEC |
| May 2, 2016 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 9,350 | $666k | 12.7% | Plan not stated | SEC |
| Mar 11, 2016 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 3,100 | $202k | 24.8% | Plan not stated | SEC |
| Feb 29, 2016 | Gabos Paul G | Director | Form 4 sale | 10,668 | $716k | 53.2% | Unusual | SEC |
| Dec 11, 2015 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 5,250 | $373k | 35.9% | Unusual | SEC |
| Sep 8, 2015 | Alvarez Cesar L | Director | Form 4 sale | 10,668 | $864k | 26.6% | Unusual | SEC |
| Aug 27, 2015 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 100,000 | $8M | 7.7% | Plan not stated | SEC |
| Jul 31, 2015 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 10,000 | $835k | 12.0% | Plan not stated | SEC |
| Jul 31, 2015 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 1,500 | $124k | 13.8% | Plan not stated | SEC |
| Jun 8, 2015 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 37,820 | $2.7M | 25.9% | Unusual | SEC |
| Jun 3, 2015 | Calabro Joseph M | President and COO | Form 4 sale | 108,071 | $7.6M | 35.2% | Unusual | SEC |
| Jun 1, 2015 | Stanley Michael D | Pres., Pediatrix Medical Group | Form 4 sale | 18,522 | $1.3M | 33.3% | Unusual | SEC |
| Jun 1, 2015 | Clark David A. | COO, Pediatrix Medical Group | Form 4 sale | 14,654 | $1M | 40.5% | Unusual | SEC |
| Mar 9, 2015 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 8,500 | $606k | 52.9% | Unusual | SEC |
| Feb 26, 2015 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 100,000 | $7.2M | 7.8% | Plan not stated | SEC |
| Feb 20, 2015 | Waldemar, Md Carlo A | Director | Form 4 sale | 10,668 | $763k | 58.5% | Unusual | SEC |
| Feb 6, 2015 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 3,200 | $226k | 15.7% | Plan not stated | SEC |
| Feb 6, 2015 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 8,250 | $577k | 11.0% | Plan not stated | SEC |
| Feb 2, 2015 | Gabos Paul G | Director | Form 4 sale | 17,584 | $1.2M | 69.9% | Unusual | SEC |
| Jan 30, 2015 | Hawk William C | COO American Anesthesiology | Form 4 sale | 3,598 | $246k | 23.8% | Plan not stated | SEC |
| Nov 14, 2014 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 51,290 | $3.2M | 3.8% | Plan not stated | SEC |
| Nov 13, 2014 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 63,440 | $4M | 4.7% | Plan not stated | SEC |
| Nov 7, 2014 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 128,833 | $8.1M | 9.1% | Plan not stated | SEC |
| Nov 5, 2014 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 169,845 | $10.6M | 11.7% | Plan not stated | SEC |
| Oct 31, 2014 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 61,592 | $3.9M | 4.6% | Plan not stated | SEC |
| Oct 30, 2014 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 8,800 | $528k | 10.5% | Plan not stated | SEC |
| Oct 30, 2014 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 40,000 | $2.5M | 23.5% | Plan not stated | SEC |
| Jul 30, 2014 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 80,000 | $4.8M | 38.1% | Unusual | SEC |
| Jun 10, 2014 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 2,252 | $132k | 9.9% | Plan not stated | SEC |
| Jun 6, 2014 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 44,596 | $2.6M | 25.5% | Unusual | SEC |
| Jun 5, 2014 | Hawk William C | COO American Anesthesiology | Form 4 sale | 6,911 | $398k | 31.5% | Unusual | SEC |
| Jun 2, 2014 | Calabro Joseph M | President and COO | Form 4 sale | 38,228 | $2.2M | 13.1% | Plan not stated | SEC |
| Jun 2, 2014 | Stanley Michael D | Pres., Pediatrix Medical Group | Form 4 sale | 18,006 | $1M | 29.1% | Unusual | SEC |
| Jun 2, 2014 | Clark David A. | COO, Pediatrix Medical Group | Form 4 sale | 16,230 | $925k | 37.9% | Unusual | SEC |
| May 9, 2014 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 79,524 | $4.5M | 34.6% | Unusual | SEC |
| May 9, 2014 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 30,000 | $1.7M | 84.9% | Unusual | SEC |
| May 8, 2014 | Calabro Joseph M | President and COO | Form 4 sale | 137,500 | $7.8M | 37.8% | Unusual | SEC |
| Feb 20, 2014 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 3,000 | $183k | 15.7% | Plan not stated | SEC |
| Feb 10, 2014 | Waldemar, Md Carlo A | Director | Form 4 sale | 10,668 | $591k | 66.6% | Unusual | SEC |
| Feb 10, 2014 | Calabro Joseph M | President and COO | Form 4 sale | 150,000 | $8.3M | 39.8% | Unusual | SEC |
| Feb 3, 2014 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 9,200 | $508k | 12.5% | Plan not stated | SEC |
| Nov 25, 2013 | Alvarez Cesar L | Director | Form 4 sale | 16,792 | $1.9M | 57.0% | Unusual | SEC |
| Nov 13, 2013 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 200,000 | $22M | 25.4% | Unusual | SEC |
| Nov 7, 2013 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 1,800 | $194k | 2.3% | Plan not stated | SEC |
| Nov 7, 2013 | Sosa Enrique | Director | Form 4 sale | 5,334 | $571k | 66.6% | Unusual | SEC |
| Nov 6, 2013 | Alvarez Cesar L | Director | Form 4 sale | 8,000 | $864k | 38.7% | Unusual | SEC |
| Sep 11, 2013 | Hawk William C | COO American Anesthesiology | Form 4 sale | 3,162 | $318k | 27.2% | Unusual | SEC |
| Sep 10, 2013 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 3,718 | $370k | 28.0% | Unusual | SEC |
| Aug 7, 2013 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 25,000 | $2.5M | 24.9% | Plan not stated | SEC |
| Aug 2, 2013 | Calabro Joseph M | President and COO | Form 4 sale | 36,154 | $3.6M | 24.2% | Plan not stated | SEC |
| Aug 1, 2013 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 345 | $34k | 3.5% | Plan not stated | SEC |
| Jun 11, 2013 | Freeman Roger K | Director | Form 4 sale | 275 | $25k | 10.3% | Plan not stated | SEC |
| Jun 3, 2013 | Calabro Joseph M | President and COO | Form 4 sale | 19,699 | $1.8M | 11.6% | Plan not stated | SEC |
| Jun 3, 2013 | Clark David A. | COO, Pediatrix Medical Group | Form 4 sale | 8,645 | $787k | 35.2% | Unusual | SEC |
| Jun 3, 2013 | Stanley Michael D | Pres., Pediatrix Medical Group | Form 4 sale | 8,906 | $811k | 27.2% | Unusual | SEC |
| Apr 2, 2013 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 3,500 | $315k | 11.9% | Plan not stated | SEC |
| Mar 4, 2013 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 72,048 | $6.1M | 16.0% | Plan not stated | SEC |
| Feb 20, 2013 | Alvarez Cesar L | Director | Form 4 sale | 8,000 | $700k | 40.8% | Unusual | SEC |
| Feb 1, 2013 | Waldemar, Md Carlo A | Director | Form 4 sale | 8,000 | $685k | 83.1% | Unusual | SEC |
| Dec 5, 2012 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 11,000 | $876k | 62.5% | Unusual | SEC |
| Dec 4, 2012 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 3,700 | $296k | 11.2% | Plan not stated | SEC |
| Nov 29, 2012 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 24,984 | $2M | 23.2% | Plan not stated | SEC |
| Nov 23, 2012 | Clark David A. | COO, Pediatrix Division | Form 4 sale | 2,019 | $156k | 10.3% | Plan not stated | SEC |
| Nov 23, 2012 | Stanley Michael D | President, Pediatrix Division | Form 4 sale | 1,470 | $113k | 5.8% | Plan not stated | SEC |
| Nov 21, 2012 | Fernandez Michael | Director | Form 4 sale | 12,931 | $989k | 50.3% | Unusual | SEC |
| Nov 20, 2012 | Clark David A. | COO, Pediatrix Division | Form 4 sale | 600 | $46k | 3.3% | Plan not stated | SEC |
| Nov 20, 2012 | Stanley Michael D | President, Pediatrix Division | Form 4 sale | 400 | $31k | 1.6% | Plan not stated | SEC |
| Nov 16, 2012 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 50,000 | $3.7M | 11.7% | Plan not stated | SEC |
| Nov 9, 2012 | Sosa Enrique | Director | Form 4 sale | 8,000 | $609k | 83.1% | Unusual | SEC |
| Nov 8, 2012 | Freeman Roger K | Director | Form 4 sale | 14,926 | $1.1M | 90.2% | Unusual | SEC |
| Nov 7, 2012 | Clark David A. | COO, Pediatrix Division | Form 4 sale | 9,881 | $762k | 35.9% | Unusual | SEC |
| Nov 7, 2012 | Stanley Michael D | President, Pediatrix Division | Form 4 sale | 9,755 | $752k | 28.9% | Unusual | SEC |
| Nov 6, 2012 | Fernandez Michael | Director | Form 4 sale | 40,000 | $3M | 60.9% | Unusual | SEC |
| Sep 11, 2012 | Goldschmidt, MD Pascal J | Director | Form 4 sale | 8,792 | $638k | 84.4% | Unusual | SEC |
| Aug 16, 2012 | Andreano Dominic J | SVP, General Counsel and Secy | Form 4 sale | 1,162 | $81k | 13.3% | Plan not stated | SEC |
| Jun 1, 2012 | Calabro Joseph M | Chief Operating Officer | Form 4 sale | 16,641 | $997k | 11.4% | Plan not stated | SEC |
| Jun 1, 2012 | Clark David A. | COO, Pediatrix Division | Form 4 sale | 9,152 | $548k | 34.1% | Unusual | SEC |
| Jun 1, 2012 | Stanley Michael D | President, Pediatrix Division | Form 4 sale | 8,649 | $518k | 26.5% | Unusual | SEC |
| Feb 28, 2012 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 100,000 | $7.5M | 26.7% | Unusual | SEC |
| Feb 27, 2012 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 13,800 | $1M | 44.5% | Unusual | SEC |
| Feb 27, 2012 | Stanley Michael D | President, Pediatrix Division | Form 4 sale | 13,853 | $1M | 40.1% | Unusual | SEC |
| Feb 21, 2012 | Hawkins Thomas W | SVP, General Counsel and Secy. | Form 4 sale | 17,973 | $1.3M | 29.3% | Unusual | SEC |
| Feb 17, 2012 | Calabro Joseph M | Chief Operating Officer | Form 4 sale | 47,121 | $3.5M | 36.2% | Unusual | SEC |
| Feb 16, 2012 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 4,500 | $338k | 17.9% | Plan not stated | SEC |
| Feb 16, 2012 | Sosa Enrique | Director | Form 4 sale | 20,000 | $1.5M | 100.0% | Unusual | SEC |
| Feb 9, 2012 | Alvarez Cesar L | Director | Form 4 sale | 6,000 | $433k | 37.5% | Unusual | SEC |
| Feb 3, 2012 | Waldemar, Md Carlo A | Director | Form 4 sale | 8,000 | $574k | 100.0% | Unusual | SEC |
| Nov 8, 2011 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 25,000 | $1.7M | 23.7% | Plan not stated | SEC |
| Sep 19, 2011 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 50,000 | $3.2M | 11.8% | Plan not stated | SEC |
| Aug 17, 2011 | Alvarez Cesar L | Director | Form 4 sale | 30,000 | $2M | 75.0% | Unusual | SEC |
| Jun 10, 2011 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 10,168 | $706k | 32.9% | Unusual | SEC |
| Jun 8, 2011 | Hawkins Thomas W | SVP, General Counsel and Secy. | Form 4 sale | 21,286 | $1.5M | 25.6% | Unusual | SEC |
| Jun 2, 2011 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 8,188 | $603k | 32.2% | Unusual | SEC |
| Jun 2, 2011 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 465 | $35k | 1.8% | Plan not stated | SEC |
| Jun 2, 2011 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 5,833 | $429k | 15.9% | Plan not stated | SEC |
| Jun 1, 2011 | Calabro Joseph M | President and COO | Form 4 sale | 15,590 | $1.1M | 10.7% | Plan not stated | SEC |
| May 20, 2011 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 1,200 | $91k | 6.4% | Plan not stated | SEC |
| May 17, 2011 | Hawkins Thomas W | SVP, General Counsel and Secy. | Form 4 sale | 81,250 | $6M | 55.0% | Unusual | SEC |
| May 4, 2011 | Wagner Karl B | Pres, American Anesthesiology | Form 4 sale | 29,852 | $2.1M | 26.4% | Unusual | SEC |
| May 4, 2011 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 1,850 | $133k | 9.5% | Plan not stated | SEC |
| May 3, 2011 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 12,500 | $905k | 36.6% | Unusual | SEC |
| Apr 28, 2011 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 10,482 | $738k | 32.6% | Unusual | SEC |
| Apr 6, 2011 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 1,185 | $83k | 5.2% | Plan not stated | SEC |
| Mar 10, 2011 | Waldemar, Md Carlo A | Director | Form 4 sale | 8,000 | $536k | 100.0% | Unusual | SEC |
| Dec 10, 2010 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 7,456 | $483k | 29.8% | Unusual | SEC |
| Dec 2, 2010 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 2,960 | $192k | 14.4% | Plan not stated | SEC |
| Nov 4, 2010 | Lopez-Blanco Vivian | Chief Financial Officer | Form 4 sale | 1,850 | $114k | 8.7% | Plan not stated | SEC |
| Jun 3, 2010 | Calabro Joseph M | President and COO | Form 4 sale | 32,019 | $1.9M | 22.2% | Plan not stated | SEC |
| Jun 2, 2010 | Hawkins Thomas W | SVP, General Counsel and Secy. | Form 4 sale | 16,664 | $947k | 19.9% | Plan not stated | SEC |
| Jun 1, 2010 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 6,755 | $378k | 42.7% | Unusual | SEC |
| Jun 1, 2010 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 8,267 | $463k | 41.2% | Unusual | SEC |
| Apr 1, 2010 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 10,347 | $611k | 34.0% | Unusual | SEC |
| Jan 5, 2010 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 24,000 | $1.5M | 9.0% | Plan not stated | SEC |
| Dec 30, 2009 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 46,427 | $2.8M | 16.0% | Plan not stated | SEC |
| Dec 28, 2009 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 57,525 | $3.5M | 19.1% | Plan not stated | SEC |
| Dec 23, 2009 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 5,735 | $343k | 15.9% | Plan not stated | SEC |
| Dec 22, 2009 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 1,104 | $66k | 3.5% | Plan not stated | SEC |
| Dec 16, 2009 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 3,786 | $226k | 11.1% | Plan not stated | SEC |
| Dec 8, 2009 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 48,899 | $2.8M | 16.7% | Plan not stated | SEC |
| Dec 3, 2009 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 51,101 | $2.9M | 17.3% | Plan not stated | SEC |
| Dec 1, 2009 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 2,570 | $145k | 7.8% | Plan not stated | SEC |
| Nov 11, 2009 | Gabos Paul G | Director | Form 4 sale | 44,000 | $2.5M | 100.0% | Unusual | SEC |
| Nov 3, 2009 | Calabro Joseph M | President and COO | Form 4 sale | 37,350 | $2M | 27.3% | Unusual | SEC |
| Oct 1, 2009 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 14,007 | $762k | 29.8% | Unusual | SEC |
| Sep 14, 2009 | Hawkins Thomas W | SVP, General Counsel and Secy. | Form 4 sale | 10,000 | $528k | 13.8% | Plan not stated | SEC |
| Sep 11, 2009 | Fernandez Michael | Director | Form 4 sale | 30,778 | $1.6M | 73.4% | Unusual | SEC |
| Sep 10, 2009 | Fernandez Michael | Director | Form 4 sale | 122,500 | $6.3M | 74.5% | Unusual | SEC |
| Sep 9, 2009 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 40,000 | $2M | 14.1% | Plan not stated | SEC |
| Sep 4, 2009 | Medel Roger Md | Chief Executive Officer | Form 4 sale | 60,000 | $3.1M | 19.7% | Plan not stated | SEC |
| Sep 4, 2009 | Fernandez Michael | Director | Form 4 sale | 70,800 | $3.6M | 30.1% | Unusual | SEC |
| Sep 2, 2009 | Wagner Karl B | Chief Financial Officer | Form 4 sale | 13,907 | $723k | 14.3% | Plan not stated | SEC |
| Sep 1, 2009 | Miller Frederick V Md | President, Pediatrix Division | Form 4 sale | 8,745 | $459k | 15.7% | Plan not stated | SEC |
| Jun 1, 2009 | Clark David A. | COO / Pediatrix Division | Form 4 sale | 4,792 | $194k | 50.4% | Unusual | SEC |
| Jun 1, 2009 | Calabro Joseph M | President and COO | Form 4 sale | 6,400 | $267k | 7.6% | Plan not stated | SEC |
| Jun 1, 2009 | Hawkins Thomas W | SVP, General Counsel and Secy. | Form 4 sale | 10,000 | $414k | 18.8% | Plan not stated | SEC |
| May 29, 2009 | Wagner Karl B | Chief Financial Officer | Form 4 sale | 4,500 | $182k | 7.1% | Plan not stated | SEC |
| Sep 4, 2007 | Wagner Karl B | Chief Financial Officer | Form 4 sale | 11,719 | $700k | 9.9% | Plan not stated | SEC |
| Sep 4, 2007 | Calabro Joseph M | PRES. & CHIEF OPERATING OFCR | Form 4 sale | 15,625 | $933k | 10.2% | Plan not stated | SEC |
| Aug 22, 2007 | Carlo Waldemar A | Director | Form 4 sale | 10,000 | $590k | 100.0% | Unusual | SEC |
| Aug 9, 2007 | Medel Roger Md | CHIEF EXECUTIVE OFFICER | Form 4 sale | 100,000 | $5.7M | 100.0% | Unusual | SEC |
| Aug 8, 2007 | Calabro Joseph M | PRES. & CHIEF OPERATING OFCR | Form 4 sale | 53,334 | $3M | 29.8% | Unusual | SEC |
| Aug 8, 2007 | Wagner Karl B | Chief Financial Officer | Form 4 sale | 37,500 | $2.1M | 27.9% | Unusual | SEC |
| Aug 8, 2007 | Hawkins Thomas W | SVP, GEN. COUNSEL & SECRETARY | Form 4 sale | 32,674 | $1.8M | 40.1% | Unusual | SEC |
| May 1, 2006 | Hawkins Thomas W | SVPGEN.COUNSEL AND SECRETARY | Form 4 sale | 22,300 | $1.1M | 36.7% | Unusual | SEC |
| May 1, 2006 | Hawkins Thomas W | SVP.GEN.COUNSEL&SECRETARY | Form 4 sale | 26,200 | $1.3M | 30.1% | Unusual | SEC |
| Feb 27, 2006 | Calabro Joseph M | PRES. & CHIEF OPERATING OFCR | Form 4 sale | 1,666 | $158k | 99.9% | Unusual | SEC |
| Feb 10, 2006 | Calabro Joseph M | PRES. & CHIEF OPERATING OFCR | Form 4 sale | 1,667 | $151k | 99.9% | Unusual | SEC |
| Feb 9, 2006 | Hawkins Thomas W | SVP, GEN. COUNSEL & SECRETARY | Form 4 sale | 32,672 | $3M | 64.4% | Unusual | SEC |
| Feb 8, 2006 | Calabro Joseph M | PRES. & CHIEF OPERATING OFCR | Form 4 sale | 67,700 | $6.2M | 55.2% | Unusual | SEC |
| Feb 8, 2006 | Wagner Karl B | Chief Financial Officer | Form 4 sale | 37,500 | $3.5M | 46.7% | Unusual | SEC |
| Jan 30, 2006 | Medel Roger Md | CHIEF EXECUTIVE OFFICER | Form 4 sale | 22,833 | $2M | 40.7% | Unusual | SEC |
| Jan 3, 2006 | Medel Roger Md | CHIEF EXECUTIVE OFFICER | Form 4 sale | 33,967 | $3M | 50.5% | Unusual | SEC |